US Stock MarketDetailed Quotes
MRVI Maravai LifeSciences
- 8.760
- -0.180-2.01%
Close Jul 15 16:00 ET
- 8.760
- 0.0000.00%
Post 16:53 ET
1.16BMarket Cap-8857P/E (TTM)
9.100High8.740Low1.85MVolume9.000Open8.940Pre Close16.44MTurnover2.39%Turnover RatioLossP/E (Static)132.83MShares12.56052wk High2.83P/B679.15MFloat Cap4.52052wk Low--Dividend TTM77.53MShs Float63.550Historical High--Div YieldTTM4.03%Amplitude4.520Historical Low8.866Avg Price1Lot Size
Maravai LifeSciences Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -18.79%64.18M | -67.28%288.95M | -63.78%74.14M | -65.04%66.87M | -71.61%68.91M | -67.65%79.03M | 10.48%883M | -10.39%204.71M | -6.61%191.26M | 11.46%242.73M |
| Operating revenue | -18.79%64.18M | -67.28%288.95M | -63.78%74.14M | -65.04%66.87M | -71.61%68.91M | -67.65%79.03M | 10.48%883M | -10.39%204.71M | -6.61%191.26M | 11.46%242.73M |
| Cost of revenue | 13.83%38.34M | -11.96%148.74M | -34.07%35.11M | -3.90%36.69M | 15.41%43.27M | -15.88%33.68M | 20.20%168.96M | 36.06%53.25M | 18.48%38.18M | -0.83%37.5M |
| Gross profit | -43.01%25.84M | -80.37%140.2M | -74.23%39.03M | -80.29%30.18M | -87.51%25.64M | -77.80%45.35M | 8.41%714.04M | -19.99%151.46M | -11.30%153.09M | 14.04%205.24M |
| Operating expense | 7.24%45.92M | 14.25%168.67M | 2.03%43.07M | 19.42%43.21M | 22.38%39.57M | 16.05%42.82M | 28.06%147.63M | 21.43%42.21M | 27.15%36.18M | 22.35%32.34M |
| Selling and administrative expenses | 5.73%40.89M | 17.12%151.39M | 3.43%38.48M | 26.20%38.86M | 26.07%35.38M | 16.48%38.67M | 29.18%129.26M | 45.43%37.2M | 16.15%30.8M | 14.53%28.06M |
| Research and development costs | 21.40%5.03M | -5.93%17.28M | -8.32%4.59M | -19.34%4.35M | -1.87%4.19M | 12.18%4.15M | 20.70%18.37M | -45.44%5.01M | 176.93%5.39M | 121.57%4.27M |
| Operating profit | -892.46%-20.07M | -105.03%-28.47M | -103.70%-4.04M | -111.15%-13.03M | -108.06%-13.93M | -98.49%2.53M | 4.24%566.42M | -29.31%109.25M | -18.89%116.9M | 12.61%172.9M |
| Net non-operating interest income expense | 36.87%-3.65M | -0.49%-18.17M | -1.26%-7.94M | -34.09%-4.21M | 94.79%-231K | -117.27%-5.79M | 40.26%-18.08M | -11.68%-7.84M | 59.19%-3.14M | 42.03%-4.43M |
| Non-operating interest income | 19.27%7.21M | 1,085.93%27.73M | 219.03%7.46M | --7.43M | --6.79M | --6.05M | --2.34M | --2.34M | --0 | --0 |
| Non-operating interest expense | -8.19%10.86M | 124.81%45.89M | 51.28%15.4M | 271.08%11.64M | 58.37%7.02M | 344.18%11.83M | -32.54%20.41M | 44.97%10.18M | -59.19%3.14M | -42.03%4.43M |
| Other net income (expense) | 203.94%1.32M | 21,112.29%664.37M | 12,186.94%668.17M | -83,050.00%-3.33M | -87.79%797K | -159.28%-1.27M | -82.23%3.13M | -95.34%-5.53M | -100.03%-4K | 217,600.00%6.53M |
| Special income (charges) | 184.40%1.21M | 18,974.67%665.71M | 10,471.27%668.12M | ---3.39M | -69.01%2.42M | -167.35%-1.44M | -79.88%3.49M | -112.54%-6.44M | --0 | --7.8M |
| -Less：Restructuring and merger&acquisition | -184.40%-1.21M | -17,901.78%-665.71M | -10,471.27%-668.12M | --3.39M | 69.01%-2.42M | 161.37%1.44M | 39.39%-3.7M | 112.54%6.44M | --0 | ---7.8M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | --208K | --0 | ---- | ---- |
| -Gain on sale of business | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non- operating income (expenses) | -36.90%106K | -273.46%-1.34M | -94.64%49K | 1,750.00%66K | -27.06%-1.62M | 2,300.00%168K | -228.32%-358K | 354.73%914K | -105.13%-4K | -42,400.00%-1.28M |
| Income before tax | -395.45%-22.41M | 12.02%617.74M | 584.41%656.19M | -118.08%-20.56M | -107.64%-13.36M | -102.71%-4.52M | 3.90%551.47M | -33.74%95.88M | -24.67%113.76M | 19.95%174.99M |
| Income tax | 108.54%271K | 1,143.42%756.11M | 8,970.30%766.17M | -138.70%-5.46M | -107.78%-1.42M | -115.89%-3.18M | -1.15%60.81M | -51.95%8.45M | -25.11%14.11M | 60.47%18.27M |
| Net income | -1,582.49%-22.68M | -128.20%-138.38M | -225.80%-109.98M | -115.15%-15.1M | -107.62%-11.94M | -100.92%-1.35M | 4.56%490.66M | -31.22%87.43M | -24.61%99.65M | 16.52%156.72M |
| Net income continuous Operations | -1,582.49%-22.68M | -128.20%-138.38M | -225.80%-109.98M | -115.15%-15.1M | -107.62%-11.94M | -100.92%-1.35M | 4.56%490.66M | -31.22%87.43M | -24.61%99.65M | 16.52%156.72M |
| Minority interest income | -727.63%-10.6M | -107.15%-19.35M | -108.08%-4.02M | -115.66%-8.64M | -106.32%-5.4M | -101.60%-1.28M | -5.83%270.46M | -30.14%49.8M | -29.45%55.18M | 0.15%85.48M |
| Net income attributable to the parent company | -17,926.87%-12.08M | -154.05%-119.03M | -381.55%-105.96M | -114.53%-6.46M | -109.18%-6.54M | -100.10%-67K | 20.97%220.21M | -32.59%37.63M | -17.59%44.47M | 44.96%71.24M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -17,926.87%-12.08M | -154.05%-119.03M | -381.55%-105.96M | -114.53%-6.46M | -109.18%-6.54M | -100.10%-67K | 20.97%220.21M | -32.59%37.63M | -17.59%44.47M | 44.96%71.24M |
| Basic earnings per share | -17,581.73%-0.09 | -153.89%-0.9 | -385.71%-0.8 | -114.71%-0.05 | -109.26%-0.05 | -100.10%-0.0005 | 5.03%1.67 | -33.33%0.28 | -26.09%0.34 | 22.73%0.54 |
| Diluted earnings per share | -17,581.73%-0.09 | -153.89%-0.9 | -385.71%-0.8 | -114.71%-0.05 | -109.43%-0.05 | -100.10%-0.0005 | 7.05%1.67 | -33.33%0.28 | -22.73%0.34 | 20.45%0.53 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg